title: [Statins in primary prevention: how to share the decision?].
abstract: Long-term treatment of hypercholesterolemia with statins diminishes the risk of cardiovascular events. Statins are recommended in secondary prevention of cardiovascular disease. In the absence of preexisting cardiovascular disease, the decision to start a statin or not is most often made by the general practitioner and his patient. An interactive decision aid, developed by the Mayo Clinic, has just been translated in French and adapted to the Swiss epidemiology of cardiovascular risk factors, with the aim of promoting shared decision-making. This paper reviews the conditions and potential benefits of shared decision-making about statin therapy in primary prevention.
authors.forename: David
authors.initials: D
authors.lastname: Nanchen
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Vonnez
authors.forename: Kevin
authors.initials: K
authors.lastname: Selby
authors.forename: Reto
authors.initials: R
authors.lastname: Auer
authors.forename: Jacques
authors.initials: J
authors.lastname: Cornuz
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003657:Decision Making; D003661:Decision Support Techniques; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D011322:Primary Prevention
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors